Aridis Pharmaceuticals, LLC is a private
biologics drug development company using formulation and
delivery technologies to provide differentiated, high value
products. Our mission is to address important diseases that
have a significant impact on life expectancy, such as
infectious diseases in children. Our solution lies in
producing dried biologicals that are stable at room
temperature and administered in “ready-to-use” formats. For
example, an oral rotavirus vaccine in a temperature stable,
quick dissolving wafer to facilitate vaccine distribution
can prevent 500,000 childhood deaths worldwide each year.
